Hancock Jaffe Laboratories, Inc.
(NASDAQ : HJLI)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
MDTMedtronic PLC
-0.23%97.280.6%$576.49m
ABTAbbott Laboratories
-0.04%82.190.8%$392.62m
TMOThermo Fisher Scientific Inc.
0.60%286.961.0%$389.95m
ISRGIntuitive Surgical, Inc.
1.89%505.922.4%$379.24m
BSXBoston Scientific Corporation
0.27%40.531.1%$319.66m
BDXBecton, Dickinson and Company
0.24%234.721.1%$311.29m
ALGNAlign Technology, Inc.
-2.52%297.996.3%$259.13m
EWEdwards Lifesciences Corporation
0.53%184.911.2%$213.60m
SYKStryker Corporation
0.19%195.851.3%$198.32m
DXCMDexCom, Inc.
1.07%149.638.3%$193.88m
BAXBaxter International Inc.
0.59%78.391.7%$174.38m
ABMDABIOMED, Inc.
0.78%252.913.3%$173.59m
ZBHZimmer Biomet Holdings, Inc.
-0.28%117.121.7%$119.40m
WATWaters Corporation
1.24%205.723.8%$113.81m
IDXXIDEXX Laboratories, Inc.
-0.12%267.413.7%$102.44m

Company Profile

Hancock Jaffe Laboratories, Inc. is a development stage medical device company, which develops biologic-based solutions that are designed to be life sustaining or life enhancing for patients with cardiovascular disease, and peripheral arterial and venous disease. Its products include The Bioprosthetic Heart Valve, The CoreoGraft, and The Venous Valve. The company was founded by Norman Jaffe on December 22, 1999 and is headquartered in Irvine, CA.